XML 45 R34.htm IDEA: XBRL DOCUMENT v3.21.4
Share-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Nov. 26, 2021
Nov. 27, 2020
Nov. 26, 2021
Nov. 27, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Performance and restricted stock units expense (credit) $ (1.8) $ 0.0 $ 1.8 $ 0.0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Stock Issued During Period, Shares, New Issues 16,109 21,351 43,406 48,241
Performance Units [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Performance and restricted stock units expense (credit) $ (4.1) $ (0.1) $ (1.5) $ (0.4)
Share-based Payment Arrangement, Expense, Tax Benefit $ (1.0) 0.0 $ (0.4) (0.1)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number     898,156  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     1,019,517  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1,917,673   1,917,673  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value     $ 14.06  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     14.38  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 14.23   $ 14.23  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms 1 year 4 months 24 days      
Restricted Stock Units [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Performance and restricted stock units expense (credit) $ (2.1) (1.9) $ (11.3) (10.9)
Share-based Payment Arrangement, Expense, Tax Benefit $ (0.5) $ (0.5) $ (2.8) $ (2.8)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number     2,285,965  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     1,155,818  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period     (121,384)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period     (65,085)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 3,255,314   3,255,314  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value     $ 12.11  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     13.89  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value     12.95  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     12.92  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 12.58   $ 12.58  
Restricted Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term     2 years 1 month 6 days  
2021 Performance unit Award | Performance Units [Member] | Tranche 1        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     2 years  
2021 Performance unit Award | Performance Units [Member] | Tranche 2        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     2 years  
2021 Performance unit Award | Performance Units [Member] | Market Condition [Member] | Tranche 1        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     0.20%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     58.10%  
2021 Performance unit Award | Performance Units [Member] | Market Condition [Member] | Tranche 2        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     0.20%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     61.30%  
2020 Performance Unit Award [Member] [Domain] | Performance Units [Member] | Tranche 1        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     3 years  
2020 Performance Unit Award [Member] [Domain] | Performance Units [Member] | Tranche 2        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     1 year  
2020 Performance Unit Award [Member] [Domain] | Performance Units [Member] | Tranche 3 [Domain]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     1 year  
2020 Performance Unit Award [Member] [Domain] | Performance Units [Member] | Market Condition [Member] | Tranche 1        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     2.30%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     32.50%  
2020 Performance Unit Award [Member] [Domain] | Performance Units [Member] | Market Condition [Member] | Tranche 2        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     0.10%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     74.10%  
2020 Performance Unit Award [Member] [Domain] | Performance Units [Member] | Market Condition [Member] | Tranche 3 [Domain]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     0.10%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     56.10%  
2022 Performance Unit Award | Performance Units [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     3 years  
2022 Performance Unit Award | Performance Units [Member] | Market Condition [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     53.50%  
2022 Performance Unit Award | Performance Units [Member] | Market Condition [Member] | Tranche 1        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     0.30%